Shanghai Labway Clinical Laboratory Co Ltd Total Liabilities
Shanghai Labway Clinical Laboratory Co Ltd total liabilities. Based on the latest financial reports, Shanghai Labway Clinical Laboratory Co Ltd (301060) has total liabilities worth CN¥666.33 Million CNY (≈ $97.51 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 301060 financial resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Shanghai Labway Clinical Laboratory Co Ltd (2013–2025)
Total liabilities of Shanghai Labway Clinical Laboratory Co Ltd from 2013 to 2025. This chart illustrates how Shanghai Labway Clinical Laboratory Co Ltd's total liabilities have evolved over time, based on quarterly financial data.
Shanghai Labway Clinical Laboratory Co Ltd Competitors by Total Liabilities
The table below lists competitors of Shanghai Labway Clinical Laboratory Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Merry Electronics Co Ltd
TW:2439
|
Taiwan | NT$22.64 Billion |
|
Xiamen Guang Pu Electronics Co Ltd
SHE:300632
|
China | CN¥1.01 Billion |
|
Jiangsu Maixinlin Aviation Science & Technology Corp. A
SHG:688685
|
China | CN¥2.11 Billion |
|
Thai Stanley Electric Public Company Limited
BK:STANLY
|
Thailand | ฿2.52 Billion |
|
AFYA LTD. CL.A DL-00005
F:1AY
|
Germany | €4.47 Billion |
|
West Coast Paper Mills Limited
NSE:WSTCSTPAPR
|
India | Rs-41.86 Billion |
|
BEIJ.JINGNENG CL.ERG.HYC1
F:BJ6
|
Germany | €64.73 Billion |
|
Entravision Communications
NYSE:EVC
|
USA | $371.43 Million |
Liability Composition Analysis (2013–2025)
This chart breaks down Shanghai Labway Clinical Laboratory Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 301060 total asset value.
Liquidity & Leverage Metrics
Shanghai Labway Clinical Laboratory Co Ltd Total Liabilities Ratios Explained
Shanghai Labway Clinical Laboratory Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.26 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.42 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shanghai Labway Clinical Laboratory Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shanghai Labway Clinical Laboratory Co Ltd (2013–2025)
The table below shows the annual total liabilities of Shanghai Labway Clinical Laboratory Co Ltd from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥647.39 Million ≈ $94.73 Million |
-19.38% |
| 2024-12-31 | CN¥803.00 Million ≈ $117.50 Million |
-20.23% |
| 2023-12-31 | CN¥1.01 Billion ≈ $147.31 Million |
-31.71% |
| 2022-12-31 | CN¥1.47 Billion ≈ $215.71 Million |
+216.56% |
| 2021-12-31 | CN¥465.67 Million ≈ $68.14 Million |
+107.77% |
| 2020-12-31 | CN¥224.13 Million ≈ $32.80 Million |
+20.57% |
| 2019-12-31 | CN¥185.89 Million ≈ $27.20 Million |
-29.09% |
| 2018-12-31 | CN¥262.15 Million ≈ $38.36 Million |
+16.17% |
| 2017-12-31 | CN¥225.66 Million ≈ $33.02 Million |
-31.46% |
| 2016-12-31 | CN¥329.25 Million ≈ $48.18 Million |
+26.39% |
| 2015-12-31 | CN¥260.50 Million ≈ $38.12 Million |
-0.62% |
| 2014-12-31 | CN¥262.14 Million ≈ $38.36 Million |
+32.03% |
| 2013-12-31 | CN¥198.54 Million ≈ $29.05 Million |
-- |
About Shanghai Labway Clinical Laboratory Co Ltd
Shanghai Labway Clinical Laboratory Co., Ltd. engages in the sale of in-vitro diagnostic products in China. The company distributes in-vitro diagnostic instruments, reagents, and related accessories and consumables. It also provides third-party medical testing, pathological diagnosis services, precision medicine, CRO, and sample bank laboratory services; scientific research technology and testing… Read more